(Q38087383)

28 August 2017

title

HDL-C: clinical equipoise and vascular endothelial function (English)

1 reference

28 August 2017

0 references

2

Jacques Genest

1 reference

28 August 2017

Steven Campbell

1

1 reference

28 August 2017

publication date

1 March 2013

1 reference

Expert Review of Cardiovascular Therapy

28 August 2017

published in

1 reference

28 August 2017

volume

11

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

343-353

1 reference

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

28 August 2017

cites work

1 reference

Major lipids, apolipoproteins, and risk of vascular disease

21 January 2018

1 reference

Familial lipoprotein disorders in patients with premature coronary artery disease

21 January 2018

1 reference

Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse

21 January 2018

1 reference

Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice

21 January 2018

1 reference

Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis.

21 January 2018

1 reference

Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies

21 January 2018

1 reference

Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease

21 January 2018

1 reference

21 January 2018

The complexity of HDL.

1 reference

Genetic causes of high and low serum HDL-cholesterol

21 January 2018

1 reference

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

21 January 2018

1 reference

Mechanisms of disease: proatherogenic HDL--an evolving field

21 January 2018

1 reference

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

21 January 2018

1 reference

Effects of torcetrapib in patients at high risk for coronary events

21 January 2018

1 reference

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

21 January 2018

1 reference

Molecular regulation of HDL metabolism and function: implications for novel therapies

21 January 2018

1 reference

The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis

21 January 2018

1 reference

Atheroprotective effects of high-density lipoproteins

21 January 2018

1 reference

Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids

21 January 2018

1 reference

Cardioprotective effects of high-density lipoproteins: the evidence strengthens

21 January 2018

1 reference

Virtual two-dimensional gel electrophoresis of high-density lipoproteins

21 January 2018

1 reference

Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry

21 January 2018

1 reference

Proteomic analysis of high-density lipoprotein

21 January 2018

1 reference

Diverse range of small peptides associated with high-density lipoprotein

21 January 2018

1 reference

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

21 January 2018

1 reference

Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr.

21 January 2018

1 reference

Combined statin and niacin therapy remodels the high-density lipoprotein proteome

21 January 2018

1 reference

Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function

21 January 2018

1 reference

High-Density Lipoprotein Proteomics: Identifying New Drug Targets and Biomarkers by Understanding Functionality.

21 January 2018

1 reference

Lipidomics reveals a remarkable diversity of lipids in human plasma

21 January 2018

1 reference

Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers

21 January 2018

1 reference

Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins

21 January 2018

1 reference

Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins

21 January 2018

1 reference

High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function

21 January 2018

1 reference

S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease

21 January 2018

1 reference

ABCA1, ABCG1, and SR-BI: Transit of HDL-associated sphingosine-1-phosphate

21 January 2018

1 reference

The role of oxidized phospholipids in atherosclerosis

21 January 2018

1 reference

Multidimensional profiling of plasma lipoproteins by size exclusion chromatography followed by reverse-phase protein arrays

21 January 2018

1 reference

HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events

21 January 2018

1 reference

High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

21 January 2018

1 reference

New insights into the regulation of HDL metabolism and reverse cholesterol transport

21 January 2018

1 reference

Update on strategies to increase HDL quantity and function

21 January 2018

1 reference

Membrane microdomains modulate oligomeric ABCA1 function: impact on apoAI-mediated lipid removal and phosphatidylcholine biosynthesis

21 January 2018

1 reference

Analysis of lipid transfer activity between model nascent HDL particles and plasma lipoproteins: implications for current concepts of nascent HDL maturation and genesis

21 January 2018

1 reference

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysis

21 January 2018

1 reference

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations

21 January 2018

1 reference

The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

21 January 2018

1 reference

Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release niacin (2 g).

21 January 2018

1 reference

Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials

21 January 2018

1 reference

High-density lipoprotein as a therapeutic target: a systematic review

21 January 2018

1 reference

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

21 January 2018

1 reference

Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis

21 January 2018

1 reference

Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review

21 January 2018

1 reference

Extended-release niacin or ezetimibe and carotid intima-media thickness.

21 January 2018

1 reference

Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review

21 January 2018

1 reference

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis.

21 January 2018

1 reference

Effects of combination lipid therapy in type 2 diabetes mellitus

21 January 2018

1 reference

Safety and tolerability of dalcetrapib

21 January 2018

1 reference

Dalcetrapib: no off-target toxicity on blood pressure or on genes related to the renin-angiotensin-aldosterone system in rats

21 January 2018

1 reference

Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial

21 January 2018

1 reference

Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial

21 January 2018

1 reference

Effects of dalcetrapib in patients with a recent acute coronary syndrome

21 January 2018

1 reference

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

21 January 2018

1 reference

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

21 January 2018

1 reference

Safety of anacetrapib in patients with or at high risk for coronary heart disease

21 January 2018

1 reference

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

21 January 2018

1 reference

Novel HDL-directed pharmacotherapeutic strategies

21 January 2018

1 reference

Is raising HDL a futile strategy for atheroprotection?

21 January 2018

1 reference

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

21 January 2018

1 reference

Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches

21 January 2018

1 reference

Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy

21 January 2018

1 reference

Antiinflammatory actions of HDL: a new insight

21 January 2018

1 reference

The metabolism and anti-atherogenic properties of HDL.

21 January 2018

1 reference

The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes

21 January 2018

1 reference

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

21 January 2018

1 reference

High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases

21 January 2018

1 reference

Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport

21 January 2018

1 reference

High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae.

21 January 2018

1 reference

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

21 January 2018

1 reference

Signaling by the high-affinity HDL receptor scavenger receptor B type I.

21 January 2018

1 reference

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

21 January 2018

1 reference

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein

21 January 2018

1 reference

High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life

21 January 2018

1 reference

ATP-binding cassette transporter G1 and high-density lipoprotein promote endothelial NO synthesis through a decrease in the interaction of caveolin-1 and endothelial NO synthase.

21 January 2018

1 reference

High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I

21 January 2018

1 reference

Human ApoA-I transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow-derived endothelial progenitor cells

21 January 2018

1 reference

High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI and ATP-binding cassette transporter G1.

21 January 2018

1 reference

Vascular-protective effects of high-density lipoprotein include the downregulation of the angiotensin II type 1 receptor

21 January 2018

1 reference

High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors

21 January 2018

1 reference

Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease

21 January 2018

1 reference

Circulating endothelial progenitor cells and cardiovascular outcomes

21 January 2018

1 reference

Understanding the role of endothelial progenitor cells in percutaneous coronary intervention

21 January 2018

1 reference

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERC.13.17

1 reference

28 August 2017

1 reference